1. SBI, Sun Pharma, Lupin among 10 stocks that buzzed in Friday’s trade

SBI, Sun Pharma, Lupin among 10 stocks that buzzed in Friday’s trade

State Bank of India share price closed 9.15 per cent up at Rs 201 on NSE after it reported 66 per cent fall in net profit figures for the quarter ended March 2016 which was in line with market expectations.

By: | New Delhi | Updated: May 27, 2016 5:02 PM
Stocks that remained in focus today State Bank of India share price closed 9.15 per cent up at Rs 201 on NSE after it reported 66 per cent fall in net profit figures for the quarter ended March 2016 which was in line with market expectations. (Photo: PTI)

The BSE Sensex and NSE Nifty rallied for the fourth consecutive day on Friday helped by the upbeat quarterly numbers of companies like BPCL and SBI. Sensex surged 286.92 points to end at 26,653.60, while NSE Nifty gained 87 points to close at 8,156.65.

Below are 11 stocks that remained in focus on Friday

State Bank of India: Share price of the public sector lender closed  9.15 per cent up at Rs 201 on NSE after it reported 66 per cent fall in net profit figures for the quarter ended March 2016 which was in line with market expectations.

PVR Ltd: Stock price of the company closed 0.71 per cent down at Rs 837.60 after it reported narrowing of its consolidated net loss to Rs 10.25 crore for the fourth quarter ended March 31, on account of successful performance of some films.

Jet Airways: Stocks of the airline were trading 3.37 per cent up at Rs 627 (9.22 am) after it reported a net profit of Rs 397.16 during the January-March quarter on the back of low fuel cost, almost flat aircraft rentals, substantial decrease in aircraft maintenance charges and higher passengers carried. The airline had reported a net loss of Rs 1,728.99 crore during the same period last year. Later, the share price of the company closed 0.35 per cent down at Rs 604.45.

Novartis India: Share price of the pharma company closed 12.45 per cent down at Rs 724.80 on disappointment over the company’s earnings for the quarter ended March 2016. Novartis India on Thursday reported a standalone net profit of Rs 21.5 crore for the March quarter.

Bharat Petroleum Corporation Ltd (BPCL): Share price of the company closed 8.71 per cent up at Rs 1007.05 after the oil marketing company reported better-than-expected financial results for the quarter ended March 31, 2016. BPCL on Thursday reported a 10.6 per cent drop in its March quarter net profit on back of slump in oil prices. Net profit in January-March quarter fell to Rs 2,549.08 crore from Rs 2,852.89 crore in the same period a year ago.

Lupin: Share price of the company closed 2.33 per cent up at Rs 1504.40 after the pharma major received an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep and Aurangabad facilities.

Sun Pharmaceutical: Sun Pharmaceuticals: Shares of the company closed 5.83 per cent up at Rs 825.50 after the pharma firm said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.

Hindustan Petroleum Corporation (HPCL): Shares of the company settled the day 9.81 per cent up at Rs 930.90 after the oil retailer posted better-than-expected financial results for the quarter ended March 31, 2016.

Oil and Natural Gas Corporation: Stocks of the company ended 1.64 per cent down at Rs 213.15 after it reported a 12 per cent rise in its March quarter net profit after the government exempted it from payment of fuel subsidy. Net profit of Rs 4,416 crore in January-March was 12.2 per cent higher than Rs 3,935 crore net profit in the same period a year ago.

Mphasis: Share price of the company closed 4.20 per cent up at Rs 492.05 after it reported a 12.8 per cent decline in consolidated net profit at Rs 154.7 crore for the quarter ended March 2016 from the year-ago period. The company, in which private equity firm Blackstone picked up a majority stake last month, had registered a net profit of Rs 177.6 crore in the January-March 2015 quarter.

Fortis Healthcare: Stocks of the company ended 5.56 per cent down at Rs 164.05 after it reported a consolidated net loss of Rs 90.86 crore for the quarter ended March 31, 2016 even as the company’s board decided to consider demerger of diagnostics business in addition to other options to monetise its inherent value. The company had posted a net loss after taxes, minority interest and share of profit of associates of Rs 17.53 crore in the corresponding period of the preceding fiscal.

 

  1. No Comments.

Go to Top